We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)
We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)
Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding
Updated: 12/31/1969
A Phase 3 Study of Carvedilol vs Variceal Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding
Status: Enrolling
Updated: 12/31/1969
Carvedilol vs Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding
Updated: 12/31/1969
A Phase 3 Study of Carvedilol vs Variceal Band Ligation vs Combination Therapy for Primary Prophylaxis of Variceal Bleeding
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of Household Purchasing Patterns, Eating and Recreation
Updated: 12/31/1969
Delay Discounting and Household Food Choices
Status: Enrolling
Updated: 12/31/1969
Study of Household Purchasing Patterns, Eating and Recreation
Updated: 12/31/1969
Delay Discounting and Household Food Choices
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perioperative Blood Pressures and Chronic Hypertension
Updated: 12/31/1969
The Association Between Home Blood Pressures and Clinic Blood Pressures in Patients Presenting for Surgery.
Status: Enrolling
Updated: 12/31/1969
Perioperative Blood Pressures and Chronic Hypertension
Updated: 12/31/1969
The Association Between Home Blood Pressures and Clinic Blood Pressures in Patients Presenting for Surgery.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Short Term Intermittent Fasting and Mediterranean Diet
Updated: 12/31/1969
Metabolic and Molecular Effects of a Mediterranean Diet and Intermittent Fasting
Status: Enrolling
Updated: 12/31/1969
Short Term Intermittent Fasting and Mediterranean Diet
Updated: 12/31/1969
Metabolic and Molecular Effects of a Mediterranean Diet and Intermittent Fasting
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)
Updated: 12/31/1969
Pilot Study Comparison of Combigan Two Times Daily (BID) vs Simbrinza Three Times Daily (TID) in Subjects Currently Treated With Latanoprost For Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)
Updated: 12/31/1969
Pilot Study Comparison of Combigan Two Times Daily (BID) vs Simbrinza Three Times Daily (TID) in Subjects Currently Treated With Latanoprost For Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Updated: 12/31/1969
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension
Updated: 12/31/1969
Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension
Updated: 12/31/1969
Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Evaluation of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Updated: 12/31/1969
A Placebo-Controlled, Randomized, Double-Blind, Parallel Group Study to Evaluate the Efficacy and Safety of ETC-1002 in Patients With Hypercholesterolemia and Hypertension
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Updated: 12/31/1969
A Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of Empagliflozin (10mg, 25mg) Administered Orally, Once Daily Over 24 Weeks in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension
Updated: 12/31/1969
A Randomised, Double-blind, Placebo-controlled, Parallel Group, Efficacy and Safety Study of Empagliflozin (10mg, 25mg) Administered Orally, Once Daily Over 24 Weeks in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials